Table 1.
ID | N | pg/mL | 95% CI | Fold- variation |
F | p | η2 | h2 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
Mean ± SE | Range | Mean ± SE | Range | ||||||||
Pregnenolone | |||||||||||
CTL M&F | 17458 | 18 | 414 ± 20 | 272–578 | 372–457 | 2.1 | (17,132)=1.72 | 0.049 | 0.20 | 0.20 ± 0.006 | 0.17–0.25 |
CIE M&F | 17461 | 19 | 434 ± 34 | 304–919 | 362–507 | 3.0 | (18,145)=2.15 | 0.007 | 0.23 | 0.23 ± 0.005 | 0.18–0.27 |
CTL M | 17459 | 17 | 424 ± 31 | 288–737 | 358–490 | 2.6 | (16,69)=1.70 | 0.076 | 0.34 | 0.34 ± 0.004 | 0.31–0.38 |
CTL F | 17460 | 17 | 399 ± 24 | 261–648 | 348–451 | 2.5 | (16,60)=1.75 | 0.071 | 0.39 | 0.39 ± 0.019 | 0.31–0.49 |
CIE M | 17462 | 19 | 451 ± 45 | 279–1113 | 358–545 | 4.0 | (18,78)=2.02 | 0.023 | 0.38 | 0.37 ± 0.017 | 0.26–0.43 |
CIE F | 17463 | 16 | 394 ± 25 | 253–577 | 340–448 | 2.3 | (15,64)=0.90 | 0.572 | 0.22 | 0.22 ± 0.009 | 0.20–0.31 |
3α,5α-THP | |||||||||||
CTL M&F | 17305 | 19 | 741 ± 40 | 375–1055 | 657–824 | 2.8 | (18,143)=2.68 | 0.0007 | 0.28 | 0.28 ± 0.011 | 0.18–0.30 |
CIE M&F | 17306 | 19 | 739 ± 36 | 460–1022 | 664–815 | 2.2 | (18,157)=2.27 | 0.004 | 0.23 | 0.23 ± 0.005 | 0.18–0.25 |
CTL M | 17448 | 18 | 683 ± 47 | 254–992 | 585–782 | 3.9 | (17,78)=2.51 | 0.005 | 0.41 | 0.41 ± 0.030 | 0.24–0.44 |
CTL F | 17449 | 17 | 818 ± 38 | 604–1360 | 737–900 | 2.3 | (16,62)=0.91 | 0.559 | 0.24 | 0.24 ± 0.004 | 0.20–0.27 |
CIE M | 17450 | 19 | 805 ± 62 | 385–1291 | 676–935 | 3.4 | (18,87)=3.60 | <0.0001 | 0.48 | 0.48 ± 0.011 | 0.42–0.52 |
CIE F | 17451 | 16 | 696 ± 33 | 406–929 | 625–766 | 2.3 | (15,67)=1.03 | 0.438 | 0.23 | 0.23 ± 0.008 | 0.16–0.26 |
3α,5α-THDOC | |||||||||||
CTL M&F | 17452 | 19 | 211 ± 21 | 94–448 | 168–254 | 4.8 | (18,125)=2.57 | 0.001 | 0.30 | 0.30 ± 0.010 | 0.21–0.33 |
CIE M&F | 17455 | 19 | 184 ± 14 | 93–333 | 155–214 | 3.6 | (18,144)=1.39 | 0.146 | 0.17 | 0.17 ± 0.003 | 0.13–0.19 |
CTL M | 17453 | 18 | 247 ± 25 | 118–498 | 187–292 | 4.2 | (17,74)=2.45 | 0.006 | 0.42 | 0.42 ± 0.017 | 0.31–0.47 |
CTL F | 17454 | 13 | 116 ± 19a | 30–243 | 75–157 | 8.2 | (12,41)=2.80 | 0.012 | 0.54 | 0.54 ± 0.024 | 0.49–0.68 |
CIE M | 17456 | 19 | 241 ± 23 | 93–512 | 193–290 | 5.5 | (18,85)=2.48 | 0.004 | 0.40 | 0.40 ± 0.017 | 0.30–0.45 |
CIE F | 17457 | 15 | 109 ± 18a | 41–292 | 70–148 | 7.1 | (14,55)=2.64 | 0.008 | 0.47 | 0.48 ± 0.011 | 0.45–0.57 |
Male (M) and female (F) mice from each genotype received four cycles of chronic intermittent ethanol (CIE) vapor exposure (CIE group) or air exposure (CTL group) (16 h/day × 4 days, followed by 72-h withdrawal), alternated with 5-day drinking test cycles using a two-bottle (15% v/v ethanol vs. water) limited access (2 h/day) drinking model. Blood samples for neuroactive steroid assays were collected 72 h after a fifth CIE or air exposure cycle. Neuroactive steroid levels are expressed as pg/mL. Significant genetic variation was estimated by one-way ANOVA; putative differences in average neuroactive steroid levels were estimated by two-way ANOVA, with 2 treatment and sex as independent variables. Heritability (h2) was estimated as the ratio of the variance between strains divided by the sum of the within-strain and between-strain variances. The variance and standard error of the estimate of h2 was computed using a jackknife procedure (Williams et al., 1996).
p < 0.001 vs. the respective male cases (two-way ANOVA, followed by Bonferroni post hoc test). ID refers to the GeneNetwork BXD phenotype ID for each trait.